Genocea Biosciences NASDAQ GNCA
- - -%
Today share price
USA
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free
Rating Finrange Index: 18 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

14.22K
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

-21.36M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

1.53
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

71.12M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

-
Upcoming events Genocea Biosciences All events
No upcoming events scheduled

Stock chart Genocea Biosciences

Stock analysis Genocea Biosciences

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
- 14.86
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
- 3.70
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
0.39 9.68
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
0.39 -0.17
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-300.29 11.19

Price change Genocea Biosciences per year

1.65$ 4.05$
Min Max

Summary analysis Genocea Biosciences

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Genocea Biosciences

Revenue and net income Genocea Biosciences

All parameters

About company Genocea Biosciences

Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products include GEN-011, an adoptive T cell therapy using neoantigen-targeted peripheral cells for ATLAS identified anti-tumor antigens that are used to manufacture peripheral blood-derived tumor-specific T cell therapy; and GEN-009, a neoantigen vaccine candidate, delivering adjuvanted synthetic long peptides spanning ATLAS-identified anti-tumor neoantigens. The company was incorporated in 2006 and is based in Cambridge, Massachusetts.
Address:
100 Acorn Park Drive, Cambridge, MA, United States, 02140
Company name: Genocea Biosciences
Issuer ticker: GNCA
ISIN: US3724274010
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2014-02-05
Sector: Healthcare
Industry: Biotechnology
Site: https://www.genocea.com

On which stock exchange are Genocea Biosciences (GNCA) stocks traded?

Genocea Biosciences (GNCA) stocks are traded on NASDAQ.

What is the ticker of Genocea Biosciences stocks (GNCA)?

The stock ticker of Genocea Biosciences’s stocks or in other words, the code is GNCA. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Genocea Biosciences (GNCA) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Genocea Biosciences (GNCA) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are Genocea Biosciences (GNCA) stocks traded?

Genocea Biosciences (GNCA) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Genocea Biosciences (GNCA) stocks today?

The current price of Genocea Biosciences stocks on 25.04.2024 is dollars. per share.

What is the dynamics of Genocea Biosciences (GNCA) stocks from the beginning of the year?

Genocea Biosciences (GNCA) quotes have increased by 0% from the beginning of the year up to dollars. per 1 stocks.

How much did Genocea Biosciences (GNCA) stocks increase in апреле 2024?

This month Genocea Biosciences (GNCA) quotes have increased by 0% to dollars. per share.

How much are Genocea Biosciences (GNCA) stocks worth?

Today, on October, 25.04.2024 Genocea Biosciences’s (GNCA) stocks cost dollars..

What is the market capitalization of Genocea Biosciences (GNCA)?

Capitalization is the market value of Genocea Biosciences (GNCA) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 25.04.2024, the market capitalization of Genocea Biosciences (GNCA) is estimated at about 14224 dollars.